In contrast, the CD4/CD8 T cell ratio turned out to be relatively constant across several neurological diseases (range 1.8–8.0), which included but were not restricted to: bacterial and viral meningitis, LNB, MS, headache, and idiopathic intracranial hypertension [37]. This evidence concerns the gene CD8A and myeloid sarcoma.